Advertisement

Effect of a Pharmacist-Driven Medication Management Intervention Among Older Adults in an Inpatient Setting

  • Sara AlosaimyEmail author
  • Alka Vaidya
  • Kevin Day
  • Gretchen Stern
Original Research Article

Abstract

Background

Older adults have a seven times greater risk than younger adults of being hospitalized due to an adverse drug event.

Objective

The objective of this study was to compare the number of potentially inappropriate medications (PIMs) on admission to the number of PIMs on discharge following pharmacist intervention.

Patients and Methods

This was a prospective, single-center pilot study performed at a tertiary medical center. Eighty-two adults aged 65 years or older on five or more medications who were admitted to the general medicine floor between December 2016 and May 2017 were included in the analysis. Pharmacists completed a review of prior admission medications and identified PIMs. Recommendations for PIMs were communicated to the medical team and documented in the patient’s electronic medical record. PIMs were measured by the use of validated screening tools and an assessment of patient-specific parameters.

Results

Fifty-two percent of our patients were taking at least one PIM. The average number of PIMs on admission was found to be 0.84 ± 1.12. Pharmacist intervention resulted in a statistically significant reduction to an average of 0.56 ± 0.91 PIMs (P < 0.01). The mean time to complete the medication therapy management (MTM) process was 49.39 ± 16.2 min per patient.

Conclusion

While pharmacist-driven MTM significantly reduced PIMs in our study, the implementation of this model in the inpatient setting faces several challenges.

Notes

Acknowledgements

The authors of this study would like to thank Kaitlin Crowley and Kevin Charles McLaughlin for their contribution to the medication therapy management process.

Compliance with Ethical Standards

Funding

No sources of funding were used to assist in the preparation of this study.

Conflict of interest

Sara Alosaimy, Gretchen Stern, Alka Vaidya, and Kevin Day declare that they have no conflict of interest with the content of the study.

References

  1. 1.
    Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296(15):1858–66.CrossRefGoogle Scholar
  2. 2.
    Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRefGoogle Scholar
  3. 3.
    Onder G, van der Cammen TJ, Petrovic M, Somers A, Rajkumar C. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing. 2013;42(3):284–91.CrossRefGoogle Scholar
  4. 4.
    O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRefGoogle Scholar
  5. 5.
    Lozano-Montoya I, Vélez-Diaz-Pallarés M, Delgado-Silveira E, Montero-Errasquin B, Cruz Jentoft AJ. Potentially inappropriate prescribing detected by STOPP-START criteria: are they really inappropriate? Age Ageing. 2015;44(5):861–6.CrossRefGoogle Scholar
  6. 6.
    Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.CrossRefGoogle Scholar
  7. 7.
    Hanlon JT, Schmader KE. The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging. 2013;30(11):893–900.CrossRefGoogle Scholar
  8. 8.
    American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.Google Scholar
  9. 9.
    O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437–52.CrossRefGoogle Scholar
  10. 10.
    Ravn-Nielsen LV, Duckert M, Lund ML, et al. Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission. A randomized clinical trial. JAMA Intern Med. 2018;178(3):375–82.  https://doi.org/10.1001/jamainternmed.2017.8274.CrossRefGoogle Scholar
  11. 11.
    Skjøt-arkil H, Lundby C, Kjeldsen LJ, et al. Multifaceted pharmacist-led interventions in the hospital setting: a systematic review. Basic Clin Pharmacol Toxicol. 2018;123(4):363–79.CrossRefGoogle Scholar
  12. 12.
    Ensing HT, Stuijt CC, Van den bemt BJ, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614–36.Google Scholar
  13. 13.
    Lee JK, Slack MK, Martin J, Ehrman C, Chisholm-Burns M. Geriatric patient care by US pharmacists in healthcare teams: systematic review and meta-analyses. J Am Geriatr Soc. 2013;61(7):1119–27.CrossRefGoogle Scholar
  14. 14.
    Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100(4):428–37.CrossRefGoogle Scholar
  15. 15.
    Weddle SC, Rowe AS, Jeter JW, Renwick RC, Chamberlin SM, Franks AS. Assessment of clinical pharmacy interventions to reduce outpatient use of high-risk medications in the elderly. J Manag Care Spec Pharm. 2017;23(5):520–4.Google Scholar
  16. 16.
    Dunn RL, Harrison D, Ripley TL. The Beers criteria as an outpatient screening tool for potentially inappropriate medications. Consult Pharm. 2011;26(10):754–63.CrossRefGoogle Scholar
  17. 17.
    Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005;53(9):1518–23.CrossRefGoogle Scholar
  18. 18.
    Walsh KA, O’Riordan D, Kearney PM, Timmons S, Byrne S. Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists’ interventions in secondary care. Age Ageing. 2016;45(2):201–9.CrossRefGoogle Scholar
  19. 19.
    Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004;2(4):257–64.CrossRefGoogle Scholar
  20. 20.
    Matanovic SM, Vlahovic-Palcevski V. Potentially inappropriate prescribing to the elderly: comparison of new protocol to Beers criteria with relation to hospitalizations for ADRs. Eur J Clin Pharmacol. 2014;70(4):483–90.CrossRefGoogle Scholar
  21. 21.
    Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, Somers A, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142–8.CrossRefGoogle Scholar
  22. 22.
    Schnipper JL, Hamann C, Ndumele CD, Liang CL, Carty MG, Karson AS, et al. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med. 2009;169(8):771–80.CrossRefGoogle Scholar
  23. 23.
    Fu AZ, Jiang JZ, Reeves JH, Fincham JE, Liu GG, Perri M 3rd. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care. 2007;45(5):472–6.CrossRefGoogle Scholar
  24. 24.
    Draft AGS updated 2018 Beers Criteria® for potentially inappropriate medications in older adults now posted for public comment [news release]. Fulton: American Geriatrics Society. https://www.americangeriatrics.org/sites/default/files/inline-files/2018%20AGS%20Beers%20Criteria%20-%20For%20Review%20Period%208.13.18.pdf. Accessed 13 Aug 2018.
  25. 25.
    McMahon CG, Cahir CA, Kenny RA, Bennett K. Inappropriate prescribing in older fallers presenting to an Irish emergency department. Age Ageing. 2014;43(1):44–50.CrossRefGoogle Scholar
  26. 26.
    Cool C, Cestac P, Laborde C, Lebaudy C, Rouch L, Lepage B, et al. Potentially inappropriate drug prescribing and associated factors in nursing homes. J Am Med Dir Assoc. 2014;15(11):850e1-9.CrossRefGoogle Scholar
  27. 27.
    Blozik E, Born AM, Stuck AE, Benninger U, Gillmann G, Clough-Gorr KM. Reduction of inappropriate medications among older nursing-home residents: a nurse-led, pre/post-design, intervention study. Drugs Aging. 2010;27(12):1009–17.CrossRefGoogle Scholar
  28. 28.
    Opondo D, Eslami S, Visscher S, de Rooij SE, Verheij R, Korevaar JC, et al. Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One. 2012;7(8):e43617.CrossRefGoogle Scholar
  29. 29.
    Steinman MA, Beizer JL, Dubeau CE, Laird RD, Lundebjerg NE, Mulhausen P. How to use the American Geriatrics Society 2015 Beers criteria—a guide for patients, clinicians, health systems, and payors. J Am Geriatr Soc. 2015;63(12):e1–7.CrossRefGoogle Scholar
  30. 30.
    Vira T, Colquhoun M, Etchells E. Reconcilable differences: correcting medication errors at hospital admission and discharge. Qual Saf Health Care. 2006;15:122–6.CrossRefGoogle Scholar
  31. 31.
    Farley TM, Shelsky C, Powell S, Farris KB, Carter BL. Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm. 2014;36(2):430–7.CrossRefGoogle Scholar
  32. 32.
    Thomas R, Huntley AL, Mann M, et al. Pharmacist-led interventions to reduce unplanned admissions for older people: a systematic review and meta-analysis of randomised controlled trials. Age Ageing. 2014;43(2):174–87.CrossRefGoogle Scholar
  33. 33.
    Farris KB, Carter BL, Xu Y, et al. Effect of a care transition intervention by pharmacists: an RCT. BMC Health Serv Res. 2014;14:406.CrossRefGoogle Scholar
  34. 34.
    Ensing HT, Stuijt CC, Van den Bemt BJ, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614–36.Google Scholar
  35. 35.
    Lehnbom EC, Stewart MJ, Manias E, Westbrook JI. Impact of medication reconciliation and review on clinical outcomes. Ann Pharmacother. 2014;48(10):1298–312.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Pharmacy ServicesBrigham and Women’s HospitalBostonUSA

Personalised recommendations